|Institutional Source||Beutler Lab|
|Gene Name||protein-O-mannosyltransferase 2|
|Is this an essential gene?||Essential (E-score: 1.000)|
|Stock #||R6370 (G1)|
|Chromosomal Location||87106861-87147968 bp(-) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||A to G at 87109199 bp|
|Amino Acid Change||Tryptophan to Arginine at position 818 (W818R)|
|Ref Sequence||ENSEMBL: ENSMUSP00000035260 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000037788] [ENSMUST00000222634]|
|Predicted Effect||probably damaging
AA Change: W818R
PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
AA Change: W818R
|Predicted Effect||probably benign
|Coding Region Coverage||
|Validation Efficiency||95% (54/57)|
FUNCTION: This gene encodes an integral membrane protein that belongs to the dolichyl-phosphate-mannose-protein mannosyltransferase family. The encoded enzyme is found in the membrane of the endoplasmic reticulum. This protein is a component of the protein O-mannosyltransferase enzyme complex which is involved in modification of the protein alpha-dystroglycan. Mutations in the human gene are a cause of different forms of muscular dystrophy-dystroglycanopathy (MDDG), type A2 (also known as Walker-Warburg syndrome), type B2 and type C2 (also known as limb-girdle muscular dystrophy). [provided by RefSeq, Sep 2015]
PHENOTYPE: Mice homozygous for one knock-out allele die between E8.5 and E9.5 with abnormal Reichert's membrane and runting. Mice homozygous for another allele die before implantation and arrest at the morula stage. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Pomt2||
(F):5'- TTCCTTGTGCTTCACAGGAAC -3'
(R):5'- CAGCACAGGGACTTAGAGTTAG -3'
(F):5'- AGCAGTGCTGTAGGTCACG -3'
(R):5'- CACAGGGACTTAGAGTTAGAGCTCC -3'